ROBICHAUD ALBERT (Chief Scientific Officer) received a stock award from SAGE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/29/2019ACC: 0001562180-19-004091
Officer· Chief Scientific Officer
Since Dec 2018
+527.00
Net shares
Net buyer
$88.4K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
1.90K acquired · 1.37K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−825.00
Price / share
—
Trade value
—
% of position
0.9%
1/11/2019
94.96K→94.14K
Common Stock
Direct
Shares
+1.90K
Price / share
—
Trade value
—
% of position
2.0%
7/25/2019
94.31K→96.20K
Common Stock
Direct
Shares
−548.00
Price / share
$161.38
Trade value
$88.44K
% of position
0.6%
7/25/2019
96.20K→95.66K
Total
Net shares
+527.00
Net value
-$88.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/11/2019 | G · Gift | −825.00 | — | — | 0.9% | 94.96K | 94.14K |
| Common Stock Direct | 7/25/2019 | A · Award | +1.90K | — | — | 2.0% | 94.31K | 96.20K |
| Common Stock Direct | 7/25/2019 | F · Tax Withholding | −548.00 | $161.38 | $88.44K | 0.6% | 96.20K | 95.66K |
| Total | +527.00 | -$88.44K | ||||||
Derivative Transactions0
No derivative transactions reported